Clearance Summary
LEVO C3 received FDA 510(k) clearance under submission number K083017, sponsored by Levo AG. The device was reviewed via the Traditional premarket notification pathway and assigned to the Physical Medicine review panel. The statutory decision date of record is 2008-10-24.
- Submission: K083017
- Applicant / Sponsor: Levo AG
- Clearance pathway: Traditional
- Review panel: Physical Medicine
- Device class: Class II
- Regulation citation: 21 CFR 890.3900
- Decision date: 2008-10-24
Classification & Regulation
This clearance is catalogued under FDA product code IPL and 21 CFR 890.3900, within the Physical Medicine review panel as a Class II device.